Ubiquigent Ltd
Company profile
DissolvedUnited Kingdom
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2024-12-31
IXBRL · 167 source facts · 26 selected values
Validation findingsXBRL valid
Accounts to 2024-12-31
IXBRL · 167 source facts · 26 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-01-01 to 2024-12-31
- Extraction status
- complete
- Numeric facts
- 113
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2509_SC362461_20241231
- Source archive
- Accounts_Monthly_Data-September2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2023-12-31
IXBRL · 142 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2023-12-31
IXBRL · 142 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2023-01-01 to 2023-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 91
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2266_SC362461_20231231
- Source archive
- Accounts_Monthly_Data-June2024.zip
Accounts to 2022-12-31
IXBRL · 143 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 143 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 91
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0027_SC362461_20221231
- Source archive
- Accounts_Monthly_Data-September2023.zip
Accounts to 2021-12-31
IXBRL · 143 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 143 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 89
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0108_SC362461_20211231
- Source archive
- Accounts_Monthly_Data-July2022.zip
Accounts to 2020-12-31
IXBRL · 142 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 142 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 89
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0090_SC362461_20201231
- Source archive
- Accounts_Monthly_Data-May2021.zip
Accounts to 2019-12-31
IXBRL · 142 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2019-12-31
IXBRL · 142 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2019-01-01 to 2019-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 88
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0078_SC362461_20191231
- Source archive
- Accounts_Monthly_Data-May2020.zip
Accounts to 2018-12-31
IXBRL · 137 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2018-12-31
IXBRL · 137 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2018-01-01 to 2018-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 82
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0069_SC362461_20181231
- Source archive
- Accounts_Monthly_Data-August2019.zip
Accounts to 2017-12-31
IXBRL · 128 source facts · 23 selected values
Not assessedlegacy record
Accounts to 2017-12-31
IXBRL · 128 source facts · 23 selected values
Not assessed
legacy record
- Reporting period
- 2017-01-01 to 2017-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 79
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0057_SC362461_20171231
- Source archive
- Accounts_Monthly_Data-August2018.zip
Registered details
SC362461- Status
- Dissolved
- Type
- Unknown
- Incorporated
- —
- Jurisdiction
- —
- Registered office
- —
Classification
0 SIC codesNo SIC classification available.
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
3 matched grantsUnlocking deubiquitinase probe discovery by high-throughput in-cell chemical proteomicsActiveEPSRC · Studentship · 2023-09-30 – 2027-09-29 · with 1 other participant£0whole project
Unlocking deubiquitinase probe discovery by high-throughput in-cell chemical proteomicsActive
EPSRC · Studentship · 2023-09-30 – 2027-09-29 · with 1 other participant
£0
whole project
Imperial College LondonleadUbiquigent Ltd
The development of novel compounds to seed a neurodegeneration drug discovery programmeLead
Innovate UK · Feasibility Studies · 2018-01-01 – 2018-12-31
£104,414
awarded
Novel chemical libraries to unlock the potential of deubiquitylase enzyme drug discoveryLead
Innovate UK · Feasibility Studies · 2017-01-01 – 2017-12-31
£133,246
awarded